Thursday
Dec 04th
Knowledge Bank
News
Research Insight
Techno Trends
Industry Reports
Articles
Industry
Events & Exhibition
Industry Projects
Case Studies
White Papers
Book Shelf
Publishing
Press Releases
E-Mailers
E-Newsletters
Webinars / Videos
Advertise
Print
Online
Subscribe





Lost Password?
No account yet? Register
First implants of cardiac devices
Friday, 11 April 2008
Biotronik GmbH & Co KG, the pioneer in wireless remote monitoring technology for patients with cardiac devices, announced today the world’s first implantations of the new Lumax 540 implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) devices in 11 hospitals in seven countries.

The new Lumax 540 platform is part of Biotronik’s most technologically advanced tachycardia product portfolio, providing extended therapy options- for individualized patient device programming as well as Biotronik Home Monitoring technology for wireless remote monitoring of patient’s cardiovascular status. A comprehensive set of diagnostic capabilities are further technical advancements included on the Lumax 540 devices to help physicians identify clinically relevant atrial fibrillation and early detection of worsening heart failure status.

“Patients could benefit from this extended battery longevity due to the need for fewer device replacements over time, thereby improving quality of life and at the same time helping to reduce healthcare costs”, commented Marlou Janssen, Vice President Global Marketing and Sales, Cardiac Rhythm Management, Biotronik.

In response to the increasing number of implanted cardiac devices, technologies which ease complex programming, enable remote monitoring and simplify patient follow-up have become increasingly important. Therefore, Lumax 540 series was specifically designed to improve effective tachyarrhythmia programming and facilitate patient follow-up with an innovative set of functionalities that help physicians efficiently automate the in-office follow-up of patients with Biotronik devices.

Furthermore, in combination with Biotronik Home Monitoring technology, the new Lumax 540 platform sets the standard for remote monitoring of patients with cardiac devices. This exclusive technology enables continuous automatic daily data transmissions of the patient’s cardiovascular status and clinically significant events to the physician from anywhere in the world using an antenna integrated in the Lumax 540 devices and the mobile telephone network.